Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

CDKI-73

🥰Excellent
Catalog No. T14919Cas No. 1421693-22-2

CDKI-73 is a potent CDK9 inhibitor (Ki: 4 nM). It shows selective toxicity to CLL cells(LD50=80 nM) versus normal B cell and normal CD34+ cell(LD50>20 uM).The inhibition of CDK9 induces apoptosis and potentiates the effect of cisplatin.

CDKI-73

CDKI-73

🥰Excellent
Purity: 98.11%
Catalog No. T14919Cas No. 1421693-22-2
CDKI-73 is a potent CDK9 inhibitor (Ki: 4 nM). It shows selective toxicity to CLL cells(LD50=80 nM) versus normal B cell and normal CD34+ cell(LD50>20 uM).The inhibition of CDK9 induces apoptosis and potentiates the effect of cisplatin.
Pack SizePriceAvailabilityQuantity
1 mg$146In Stock
2 mg$198In Stock
5 mg$308In Stock
10 mg$443In Stock
25 mg$732In Stock
50 mg$987In Stock
100 mg$1,390In Stock
1 mL x 10 mM (in DMSO)$323In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "CDKI-73"

Select Batch
Purity:98.11%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
CDKI-73 is a potent CDK9 inhibitor (Ki: 4 nM). It shows selective toxicity to CLL cells(LD50=80 nM) versus normal B cell and normal CD34+ cell(LD50>20 uM).The inhibition of CDK9 induces apoptosis and potentiates the effect of cisplatin.
Targets&IC50
CDK6:37.68 nM, CDK2:3.27 nM, CDK9:5.78 nM, CDK4:8.18 nM, CDK7:134.26 nM, CDK1:8.17 nM
In vitro
CDKI-73, one of the most potent CDK9 inhibitors, against a panel of AML cell lines and samples derived from 97 patients.?CDKI-73 induced cancer cells undergoing apoptosis through transcriptional downregulation of anti-apoptotic proteins Bcl-2, Mcl-1 and XIAP by majorly targeting CDK9[3].
In vivo
CDKI-73 exhibited a favorable pharmacokinetic profile with oral bioavailability of F = 56% following a single intravenous bolus dose at 2 mg/kg and an oral dose at 10 mg/kg in mice [1].
Chemical Properties
Molecular Weight394.45
FormulaC15H15FN6O2S2
Cas No.1421693-22-2
SmilesCNc1nc(C)c(s1)-c1nc(Nc2cccc(c2)S(N)(=O)=O)ncc1F
Relative Density.1.524 g/cm3 (Predicted)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 52 mg/mL (131.83 mM)
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.5352 mL12.6759 mL25.3518 mL126.7588 mL
5 mM0.5070 mL2.5352 mL5.0704 mL25.3518 mL
10 mM0.2535 mL1.2676 mL2.5352 mL12.6759 mL
20 mM0.1268 mL0.6338 mL1.2676 mL6.3379 mL
50 mM0.0507 mL0.2535 mL0.5070 mL2.5352 mL
100 mM0.0254 mL0.1268 mL0.2535 mL1.2676 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy CDKI-73 | purchase CDKI-73 | CDKI-73 cost | order CDKI-73 | CDKI-73 chemical structure | CDKI-73 in vivo | CDKI-73 in vitro | CDKI-73 formula | CDKI-73 molecular weight